Company · Welwyn Garden City
Roche Products Limited
Wholesale of pharmaceutical goods
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Roche Products Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 41
- Benan Cuma 2020-2024 View profile
- Kezia Jayn Vitug 2019-2020 View profile
- Geoffrey John Twist 2017-2026 View profile
- Timothy Edwin Kelly 2017-2018 View profile
- Christiane Schumacher 2016-2017 View profile
- Richard William Erwin 2015-2025 View profile
- Richard John Wright 2015-2015 View profile
- Tobin Charles Schilke 2014-2016 View profile
- Beat Christoph Kraehenmann 2014-2022 View profile
- Jayson Donald Alexander Dallas 2013-2015 View profile
- Mark Lloyd Williams 2012-2014 View profile
- Christopher Stuart Parker 2012-2017 View profile
- Jan Van Den Boer 2004-2012 View profile
- Andreas Brabeck Letmathe 2004-2012 View profile
- James Karin Jnr Lennertz 2002-2004 View profile
- John Mcmillan Melville 2000-2012 View profile
- Alexander Grant 1999-2004 View profile
- Vic Ackermann 1997-2000 View profile
- Williamson, Basil, Doctor 1997-1999 View profile
- Franz Bernhard Humer 1995-1999 View profile
- Gavin Keith Bell 1995-1999 View profile
- John Phillip Rackley 1995-1999 View profile
- Nicol Adrian Holladay 1994-1997 View profile
- David James Jackson 1994-2001 View profile
- Mcclymont, Thomas Mcdonald, Doctor 1993-1997 View profile
- Dr Kenneth John Stone 1992-1994 View profile
- Dr James Lyndon Davies 1999 View profile
- Professor John Anthony Goldsmith 1991 View profile
- Paul Anthony Newton-Syms 1992 View profile
- Dr Armin Maximilian Kessler 1995 View profile
- David Griffiths 1994 View profile
- John Nevill Hornibrook 1993 View profile
- David Peter Clough 1999 View profile
- Summerfield, Peter John Frederick, Doctor 1991 View profile
- Dr Kenneth Martin Taylor 1994 View profile
- Leuberger, Andres Friedrich, Doctor 1999 View profile
- Soames, Arthur Nicholas Winston, Hon 1992 View profile
- Mandy Elizabeth Robertson 2018-2019 View profile
- Olufunke Abimbola 2015-2018 View profile
- Richard David Daniel 1994-2015 View profile
- Derek John Bailey 1993 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
Public contracts won
8 contracts · £15,529,352 totalFrom Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.
-
NHS National Generic Pharmaceuticals - Wave 16a
NHS National Framework for Generics Pharmaceuticals Wave 16a Offer reference number: CM/PHG/24/5714 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or per…
Framework -
Antiviral Generic Medicines
Supply of Antiviral Generic Medicines to NHS Scotland
Framework -
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.
CM/PHR/20/5591/01 - Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsCM/PHR/20…
Framework -
Tocilizumab Subcutaneous Injection (RoActemra®)
The supply of Tocilizumab Subcutaneous Injections (RoActemra®) to NHS Scotland which used to treat licensed indications. This medicine is not being procured to treat Covid-19.
Framework -
Transitional Drugs 7
The provision of Drugs that have recently lost exclusivity
-
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion f…
Framework -
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
NHS Branded Medicines Tranche B - Lot 1 - London & South of England - CM/PHR/25/5731 Period of Framework Agreement: 1 September 2026 to 31 August 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or per…
Framework -
Generic, Branded Generic & Proprietary Medicinal Products - Group 18
Generic, Branded Generic & Proprietary Medicinal Products - Group 18 (6345404)
About
- What it does
- Wholesale of pharmaceutical goods; Other research and experimental development on natural sciences and engineering
- Incorporated
- 14/12/1908
- Registered office
- Welwyn Garden City
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Roche Holding (UK) Limited
75-100% shares, 75-100% voting, appoints directors · notified 2016-06-01
Group
- Roche Products Limited
is controlled by Roche Holding (UK) Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-06-01 · source: Companies House PSC register
Ultimately controlled by Roche Holding (UK) Limited.
12 other companies in this group
- Intermune Holdings Limited
- LKM Innovations Limited
- Disetronic Medical Systems Limited
- AVL Medical Instruments U.K. Limited
- 07700275
- Roche Products Pension Trust Limited
- Lumiradx UK LTD
- Ventana Medical Systems Limited
- Roche Healthcare Trustee Limited
- Roche Diagnostics Limited
- Roche Diabetes Care Limited
- Roche Holding (UK) Limited
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Grants received
1 grant · £46,797 total360Giving data, published by funders. Coverage only includes funders who publish their grants to 360Giving, so these figures are a floor, not a complete picture.
Top funders
- Department for Business, Energy and Industrial Strategy · £46,797
Most recent
- Department for Business, Energy and Industrial Strategy
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
5 directors on the board
- Kathryn Rowbotham Director · appointed 2025
- Robert Ferraro Director · appointed 2022
- Scott Davis Director · appointed 2025
- Danielle Lisa Loewenstein Director · appointed 2025
- Dr Allan Pamba Director · appointed 2026
First-time vs portfolio directors
First-time (2)
- Robert Ferraro Director · appointed 2022
- Dr Allan Pamba Director · appointed 2026
Portfolio (3)
- Kathryn Rowbotham Director · appointed 2025
- Scott Davis Director · appointed 2025
- Danielle Lisa Loewenstein Director · appointed 2025
Left in the last 12 months
- Geoffrey John Twist Director · appointed 2017 · resigned 2026
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 00100674
- Status
- Active
- Type
- Private Limited Company
- Accounts next due
- 30/09/2026
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data